Literature DB >> 20603603

Regulation of Myc by miR-34c: A mechanism to prevent genomic instability?

Ian G Cannell1, Martin Bushell.   

Abstract

Over the past 8 years several lines of compelling evidence have indicated that microRNAs are critical downstream effectors of classic oncogene/tumour suppressor networks. The archetypal examples of oncogene and tumour suppressor microRNAs are the miR-17-92 (oncomir 1) polycistron and miR-34 respectively. Whilst the involvement of these two opposing families of microRNAs in oncogenesis has been known for some time, the mRNA targets through which they exert their phenotypes are only just beginning to be uncovered. Moreover, several recent reports have demonstrated that the relevant physiological targets of certain individual microRNAs are actually fairly limited, with repression of just one or two major targets sufficient to explain the observed phenotype. In this review we will discuss the emerging role of microRNAs in tumourigenesis with a specific focus on miR-34c-dependent regulation of Myc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20603603

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  26 in total

1.  microRNA-34c is a novel target to treat dementias.

Authors:  Athanasios Zovoilis; Hope Y Agbemenyah; Roberto C Agis-Balboa; Roman M Stilling; Dieter Edbauer; Pooja Rao; Laurent Farinelli; Ivana Delalle; Andrea Schmitt; Peter Falkai; Sanaz Bahari-Javan; Susanne Burkhardt; Farahnaz Sananbenesi; Andre Fischer
Journal:  EMBO J       Date:  2011-09-23       Impact factor: 11.598

2.  Sirolimus induces apoptosis and reverses multidrug resistance in human osteosarcoma cells in vitro via increasing microRNA-34b expression.

Authors:  Yan Zhou; Rui-hua Zhao; Kuo-fu Tseng; Kun-peng Li; Zhi-gang Lu; Yuan Liu; Kun Han; Zhi-hua Gan; Shu-chen Lin; Hai-yan Hu; Da-liu Min
Journal:  Acta Pharmacol Sin       Date:  2016-02-29       Impact factor: 6.150

3.  MicroRNA-10a-5p and microRNA-34c-5p in laryngeal epithelial premalignant lesions: differential expression and clinicopathological correlation.

Authors:  Yanping Hu; Honggang Liu
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-09-30       Impact factor: 2.503

4.  MicroRNAs and cancer: Key paradigms in molecular therapy.

Authors:  Weige Tan; Bodu Liu; Shaohua Qu; Gehao Liang; Wei Luo; Chang Gong
Journal:  Oncol Lett       Date:  2017-12-19       Impact factor: 2.967

Review 5.  c-MYC-miRNA circuitry: a central regulator of aggressive B-cell malignancies.

Authors:  Jiangchuan Tao; Xiaohong Zhao; Jianguo Tao
Journal:  Cell Cycle       Date:  2014-01-06       Impact factor: 4.534

Review 6.  MicroRNAs in pancreatic cancer metabolism.

Authors:  Pankaj K Singh; Randall E Brand; Kamiya Mehla
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-04-17       Impact factor: 46.802

Review 7.  MicroRegulators come of age in senescence.

Authors:  Myriam Gorospe; Kotb Abdelmohsen
Journal:  Trends Genet       Date:  2011-05-16       Impact factor: 11.639

8.  Association of germline microRNA SNPs in pre-miRNA flanking region and breast cancer risk and survival: the Carolina Breast Cancer Study.

Authors:  Jeannette T Bensen; Chiu Kit Tse; Sarah J Nyante; Jill S Barnholtz-Sloan; Stephen R Cole; Robert C Millikan
Journal:  Cancer Causes Control       Date:  2013-03-23       Impact factor: 2.506

Review 9.  Roles of epigenome in mammalian spermatogenesis.

Authors:  Ning Song; Daisuke Endo; Takehiko Koji
Journal:  Reprod Med Biol       Date:  2013-08-22

10.  Posttranscriptional regulation of gene expression-adding another layer of complexity to the DNA damage response.

Authors:  Jorge Boucas; Arina Riabinska; Mladen Jokic; Grit S Herter-Sprie; Shuhua Chen; Katja Höpker; H Christian Reinhardt
Journal:  Front Genet       Date:  2012-08-25       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.